Dataset Information


CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells.

ABSTRACT: Enhancer of zeste homologue 2 (EZH2) is the catalytic subunit of Polycomb repressive complex 2 (PRC2) and catalyses the trimethylation of histone H3 on Lys 27 (H3K27), which represses gene transcription. EZH2 enhances cancer-cell invasiveness and regulates stem cell differentiation. Here, we demonstrate that EZH2 can be phosphorylated at Thr 487 through activation of cyclin-dependent kinase 1 (CDK1). The phosphorylation of EZH2 at Thr 487 disrupted EZH2 binding with the other PRC2 components SUZ12 and EED, and thereby inhibited EZH2 methyltransferase activity, resulting in inhibition of cancer-cell invasion. In human mesenchymal stem cells, activation of CDK1 promoted mesenchymal stem cell differentiation into osteoblasts through phosphorylation of EZH2 at Thr 487. These findings define a signalling link between CDK1 and EZH2 that may have an important role in diverse biological processes, including cancer-cell invasion and osteogenic differentiation of mesenchymal stem cells.


PROVIDER: S-EPMC3076036 | BioStudies | 2011-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3151093 | BioStudies
2020-01-01 | S-EPMC7284218 | BioStudies
2019-01-01 | S-EPMC6459869 | BioStudies
1000-01-01 | S-EPMC3671259 | BioStudies
2013-01-01 | S-EPMC3617464 | BioStudies
1000-01-01 | S-EPMC2995064 | BioStudies
2018-01-01 | S-EPMC6282306 | BioStudies
2013-01-01 | S-EPMC3965909 | BioStudies
2010-01-01 | S-EPMC3292434 | BioStudies
2019-01-01 | S-EPMC6771381 | BioStudies